BrightSpring Health Services, Inc. (BTSG)
NASDAQ (NGS) NASDAQ (NGS) Primary 
BTSG vs. MEDP: Which Stock Is the Better Value Option?
Investors interested in stocks from the Medical Services sector have probably already heard of BrightSpring Health Services, Inc. (BTSG) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
Is BrightSpring Health Services, Inc. (BTSG) Outperforming Other Medical Stocks This Year?
Here is how BrightSpring Health Services, Inc. (BTSG) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
Earnings Estimates Moving Higher for BrightSpring Health Services, Inc. (BTSG): Time to Buy?
BrightSpring Health Services, Inc. (BTSG) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
BrightSpring Health Services, Inc. (BTSG) Hits Fresh High: Is There Still Room to Run?
BrightSpring Health Services, Inc. (BTSG) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
BTSG or MEDP: Which Is the Better Value Stock Right Now?
Investors interested in Medical Services stocks are likely familiar with BrightSpring Health Services, Inc. (BTSG) and Medpace (MEDP). But which of these two stocks is more attractive to value investors?
Are Medical Stocks Lagging BrightSpring Health Services, Inc. (BTSG) This Year?
Here is how BrightSpring Health Services, Inc. (BTSG) and Arcutis Biotherapeutics, Inc. (ARQT) have performed compared to their sector so far this year.
BTSG vs. MEDP: Which Stock Is the Better Value Option?
Investors with an interest in Medical Services stocks have likely encountered both BrightSpring Health Services, Inc. (BTSG) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity right now?
BrightSpring Health Services, Inc. (BTSG) Q3 2025 Earnings Call Transcript
BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q3 2025 Earnings Call October 28, 2025 4:30 PM EDT Company Participants Jon Rousseau - Chairman, President & CEO Jennifer Phipps - CFO, Chief Accounting Officer & Principal Accounting Office Conference Call Participants David Deuchler - Gilmartin Group LLC Albert Rice - UBS Investment Bank, Research Division David Larsen - BTIG, LLC, Research Division Charles Rhyee - TD Cowen, Research Division Kieran Ryan - Deutsche Bank AG, Research Division Brian Tanquilut - Jefferies LLC, Research Division Ann Hynes - Mizuho Securities USA LLC, Research Division Matthew Gillmor - KeyBanc Capital Markets Inc., Research Division Joanna Gajuk - BofA Securities, Research Division Erin Wilson Wright - Morgan Stanley, Research Division Stephen Baxter - Wells Fargo Securities, LLC, Research Division Lawrence Solow - CJS Securities, Inc. Presentation Operator Good day, and thank you for standing by. Welcome to the BrightSpring Health Services Third Quarter 2025 Earnings Conference Call.
BrightSpring Health Services, Inc. (BTSG) Tops Q3 Earnings and Revenue Estimates
BrightSpring Health Services, Inc. (BTSG) came out with quarterly earnings of $0.3 per share, beating the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.11 per share a year ago.
Can BrightSpring Health Services, Inc. (BTSG) Keep the Earnings Surprise Streak Alive?
BrightSpring Health Services, Inc. (BTSG) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
BrightSpring Health Services, Inc. (BTSG) Upgraded to Strong Buy: What Does It Mean for the Stock?
BrightSpring Health Services, Inc. (BTSG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
BrightSpring Health Services, Inc. (BTSG) Q2 2025 Earnings Call Transcript
BrightSpring Health Services, Inc. (NASDAQ:BTSG ) Q2 2025 Earnings Conference Call August 1, 2025 8:30 AM ET Company Participants David Deuchler - Corporate Participant Jennifer A. Phipps - CFO, Chief Accounting Officer & Principal Accounting Office Jon B.
